API Intermediates
| S.No. | Name of the Compound | Chemical Structure | CAS No. | API |
|---|---|---|---|---|
| 1 | 6-Chloro-3-methyluracil |
|
4318-56-3 | Alogliptin |
| 2 | 2-(Bromomethyl)benzonitrile |
|
22115-41-9 | Alogliptin |
| 3 | 2-((6-Chloro-3-methyl-2,4-dioxo3,4-dihydropyridine-1(2H)-yl) methyl) benzonitrile |
|
865758-96-9 | Alogliptin |
| 4 | R-3-Aminopiperidine dihydrochloride |
|
334618-23-4 | Alogliptin |
| 5 | Ethyl 1-benzyl-3-oxo-piperidine-4-carboxylate hydrochloride |
|
52763-21-0 | Adagrasib |
| 6 | 7-Benzyl-2,4-dichloro-5,6,7,8-tetrahydropyrido[3,4-d] pyrimidine |
|
1059735-34-0 | Adagrasib |
| 7 | tert-Butyl 2,4-dichloro-5,6-dihydropyrido [3,4-d]pyrimidine-7(8H)carboxylate |
|
916420-27-4 | Adagrasib |
| 8 | (S)-4-Methoxy-2-((1-methylpyrrolidin-2-yl) methoxy)-5,6,7,8-tetrahydropyrido[3,4-d] pyrimidine |
|
2490716-99-7 | Adagrasib |
| 9 | (S)-2-(Piperazin-2-yl)acetonitrile dihydrochloride |
|
2158301-19-8 | Adagrasib |
| 10 | (R)-3-(Hydroxymethyl)piperazine-1-carboxylate |
|
278788-66-2 | Adagrasib |
| 11 | 1-Bromo-8-chloronaphthalene |
|
20816-79-9 | Adagrasib |
| 12 | t-Butyl 3-oxo cyclobutyl carbamate |
|
154748-49-9 | Abrocitinib |
| 13 | Benzyl (3-oxo cyclobutyl) carbamate |
|
130369-36-7 | Abrocitinib |
| 14 | 4-(Pyrrolidine sulfonyl methyl)nitrobenzene |
|
340041-91-0 | Almotriptan |
| 15 | 4-(Pyrrolidine sulfonylmethyl) benzene amine |
|
334981-10-1 | Almotriptan |
| 16 | 4-Fluoro-3-nitrobenzonitrile |
|
1009-35-4 | Alectinib |
| 17 | (2S)-1-[[(2-Amino-1,1-dimethyl ethyl)amino]acetyl]-2-pyrrolidinecarbonitrile |
|
794460-89-2 | Anagliptin |
| 18 | 2-Methylpyrazolo[1,5-a]pyrimidine-6-carboxylic acid |
|
739364-95-5 | Anagliptin |
| 19 | 2-Methyl-1,2-propane diamine |
|
811-93-8 | Anagliptin |
| 20 | tert-Butyl (2-amino-2-methylpropyl) carbamate |
|
95034-05-2 | Anagliptin |
| 21 | 3-Bromo-5-fluorophenol |
|
433939-27-6 | Belzutifan |
| 22 | 4-Fluoro-7-(methylsulfonyl)-2,3-dihydro-1H-inden-1-one |
|
1672665-29-0 | Belzutifan |
| 23 | 2-(3-Bromophenoxy)-N-(propane-2-yl) acetamide |
|
1016863-29-8 | Belumosudil |
| 24 | 4-(4-Bromo-3-formyl phenoxy) benzonitrile |
|
906673-54-9 | Crisaborole |
| 25 | N-(4-Cyanophenyl)-glycine |
|
42288-26-6 | Dabigatran |
| 26 | Ethyl 3-(Pyridin-2-yl amino) propanoate |
|
103041-38-9 | Dabigatran |
| 27 | 4-(Methylamino)-3-nitrobenzoic Acid |
|
41263-74-5 | Dabigatran |
| 28 | 3-[[[2-[[(4-Cyanophenyl) amino] methyl]... |
|
211915-84-3 | Dabigatran |
| 29 | 1H-Imidazole-4-carboxylic acid |
|
1072-84-0 | Dexmedetomidine |
| 30 | 3-(2-Methoxy-3-nitrophenyl)-1-methyl-1H-1,2,4-triazole |
|
1609394-08-2 | Deucravacitinib |
| 31 | 4,6-Dichloropyridazine-3-carboxylic acid |
|
1040246-87-4 | Deucravacitinib |
| 32 | Methyl 3-amino-2-fluorobenzoate |
|
1195768-18-3 | Dabrafenib |
| 33 | 2,2-Dimethylpropanethioamide |
|
630-22-8 | Dabrafenib |
| 34 | Tert-Butyl (S)-(1-hydroxypropan-2-yl)carbamate |
|
147252-84-4 | Darolutamide |
| 35 | 2-(Bromomethyl)-2-butylhexanoic acid |
|
100048-86-0 | Elobixibat |
| 36 | 7-Bromo-3,3-dibutyl-8-methoxy-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one |
|
439089-27-7 | Elobixibat |
| 37 | 5-Bromo-3-(((R)-1-methyl pyrrolidine-2-yl) methyl)-1H-indole |
|
143322-57-0 | Eletriptan |
| 38 | Phenyl vinyl sulfone |
|
5535-48-8 | Eletriptan |
| 39 | 3-Aminophenyl acetylene / 3-Ethynylaniline |
|
54060-30-9 | Erlotinib |
| 40 | 2,4-Bis(trifluoromethyl)-5,6,7,8-tetrahydropyrido-[3,4-d]pyrimidine hydrochloride |
|
911636-86-7 | Gemigliptin |
| 41 | (S)-4-(tert-Butoxy)-3-((5,5-difluoro-2-oxopiperidin-1-yl)methyl)-4-oxobutanoic acid |
|
911635-43-3 | Gemigliptin |
| 42 | 1-Methyl-1H-indazole-3-carboxylic acid |
|
50890-83-0 | Granisetron |
| 43 | 1H-Pyrazolo[3,4-d]pyrimidin-4-amine |
|
2380-63-4 | Ibrutinib |
| 44 | 4-Amino-3-bromo-1H-pyrazolo[3,4-d]pyrimidine |
|
83255-86-1 | Ibrutinib |
| 45 | 4-Amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidine |
|
151266-23-8 | Ibrutinib |
| 46 | 2-(Chloromethyl)-4-methyl quinazoline |
|
109113-72-6 | Linagliptin |
| 47 | 8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione |
|
93703-24-3 | Linagliptin |
| 48 | 8-Bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
|
666816-98-4 | Linagliptin |
| 49 | 8-Bromo-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
|
853029-57-9 | Linagliptin |
| 50 | (R)-tert-Butyl 3-amino piperidine-1-carboxylate |
|
309956-78-3 | Linagliptin / Alogliptin / Trelagliptin |
| 51 | 4-Chloro-2-(methylthio)pyrimidine |
|
49844-90-8 | Lazertinib |
| 52 | 3-Phenyl-1H-pyrazole-4-carbaldehyde |
|
26033-20-5 | Lazertinib |
| 56 | N-Methyl-2-(3-(1-methyl-1,2,3,6-tetrahydro pyridin-4-yl)-1H-indol-5-yl)ethane sulfonamide |
|
121679-20-7 | Naratriptan |
| 57 | 2-Methylbenzhydryl chloride |
|
41870-52-4 | Orphenadrine |
| 58 | 2-Fluoro-5-formylbenzonitrile |
|
218301-22-5 | Olaparib |
| 59 | 2-Fluoro-5-formylbenzoic acid |
|
550363-85-4 | Olaparib |
| 60 | 2,5-Dichloro-4,6-dimethylnicotinonitrile |
|
91591-63-8 | Opicapone |
| 61 | 3,4-Dihydroxy-5-nitrobenzoic acid |
|
84211-30-3 | Opicapone |
| 62 | (S)-3-((tert-Butoxy carbonyl)amino)butanoic acid |
|
158851-30-0 | Olutasidenib |
| 63 | 5-Bromo-2-fluoro-1,3-dimethylbenzene |
|
99725-44-7 | Orforglipron |
| 64 | 4-Bromo-5-fluoro-1-methyl-1H-indazole |
|
2633010-42-9 | Orforglipron |
| 65 | 2,3-Dimethyl-2H-indazol-6-amine |
|
44473-72-0 | Pazopanib |
| 66 | 3-Methyl-6-nitro-2H-indazole |
|
6494-19-6 | Pazopanib |
| 67 | 5-Amino-2-methylbenzenesulfonamide |
|
6973-09-7 | Pazopanib |
| 68 | N-(2-Chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine |
|
444731-75-3 | Pazopanib |
| 69 | 4-((1H-1,2,4-Triazol-1-yl)methyl)benzeneamine |
|
119192-10-8 | Rizatriptan |
| 70 | (S)-3-(1-(Dimethylamino)ethyl)phenol |
|
139306-10-8 | Rivastigmine |
| 71 | 2,6-Difluorobenzyl bromide |
|
85118-00-9 | Relugolix / Rufinamide |
| 72 | N-Cyanoacetylurethane |
|
6629-04-5 | Resmetirom |
| 73 | 6-(4-Amino-2,6-dichlorophenoxy)-4-isopropylpyridazin-3(2H)-one |
|
920509-28-0 | Resmetirom |
| 74 | 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride |
|
762240-92-6 | Sitagliptin |
| 75 | Boc-(R)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid |
|
486460-00-8 | Sitagliptin |
| 77 | 2-tert-Butyl 4-ethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate |
|
86770-31-2 | Sunitinib |
| 78 | Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate |
|
2199-59-9 | Sunitinib |
| 79 | N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide |
|
356068-86-5 | Sunitinib |
| 80 | 2-(Bromomethyl)-4-fluorobenzonitrile |
|
421552-12-7 | Trelagliptin |
| 81 | 2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyridine-1(2H)-yl) methyl)-5-fluoro benzonitrile |
|
865759-24-6 | Trelagliptin |
| 82 | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine |
|
3680-69-1 | Tofacitinib / Baricitinib / Ruxolitinib / Abrocitinib / Ritlecitinib |
| 83 | 2-Amino-2-cyanoacetamide |
|
6719-21-7 | Temozolomide |
| 84 | 5-Amino-1H-imidazole-4-carboxamide Monohydrate |
|
360-97-4 | Temozolomide |
| 85 | 5-Amino-N1-methyl-1H-imidazole-1,4-dicarboxamide |
|
188612-53-5 | Temozolomide |
| 86 | 5-[(2R)-2-Aminopropyl]-2-methoxybenzenesulfonamide |
|
112101-81-2 | Tamsulosin |
| 87 | 1-(2-Bromoethoxy)-2-ethoxybenzene |
|
3259-03-8 | Tamsulosin |
| 88 | 3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride |
|
1173081-96-3 | Tazometostat |
| 89 | 2-Amino-3,5-dibromo pyrazine |
|
24241-18-7 | Upadacitinib |
| 90 | 2-Bromo-5-tosyl-5H-pyrrolo[2,3-b]pyrazine |
|
1201186-54-0 | Upadacitinib |
| 91 | tert-Butyl (5-tosyl-5H-pyrrolo[2,3-b] pyrazin-2-yl) carbamate |
|
1201187-44-1 | Upadacitinib |
| 92 | 5-Hexynoic acid |
|
53293-00-8 | Vibegron |
| 93 | 4-Pentyn-1-ol |
|
5390-04-5 | Vibegron |
| 94 | 5-Bromo-7-methyl-1H-indazole |
|
156454-43-2 | Zavegepant |
